1. Home
  2. ACR vs UNCY Comparison

ACR vs UNCY Comparison

Compare ACR & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ACR

ACRES Commercial Realty Corp.

HOLD

Current Price

$9.97

Market Cap

146.1M

Sector

Real Estate

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

SELL

Current Price

$3.68

Market Cap

150.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ACR
UNCY
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
146.1M
150.1M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
ACR
UNCY
Price
$9.97
$3.68
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $28.40
AVG Volume (30 Days)
53.7K
★ 863.2K
Earning Date
10-28-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $79,946,000.00
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10,812.60
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.92
$3.67
52 Week High
$24.61
$8.74

Technical Indicators

Market Signals
Indicator
ACR
UNCY
Relative Strength Index (RSI) 26.46 23.16
Support Level $9.92 N/A
Resistance Level $14.97 $5.86
Average True Range (ATR) 0.47 0.20
MACD 0.06 -0.06
Stochastic Oscillator 4.99 7.14

Price Performance

Historical Comparison
ACR
UNCY

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding, and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralized debt obligations, and private equity investments mainly issued by financial institutions.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: